Akoya Biosciences, Inc. Sustainability Profile
Akoya Biosciences, Inc., a leading player in the life sciences industry, is headquartered in the United States and operates across major regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in spatial biology, focusing on advanced multiplexed imaging solutions that enable researchers to explore the complexities of tissue microenvironments. Akoya's core offerings include the Phenoptics™ platform, which provides high-parameter analysis of tissue samples, and the CODEX® system, known for its unique ability to visualise multiple biomarkers simultaneously. These innovative products set Akoya apart in the competitive landscape of biomarker discovery and diagnostics. With a commitment to enhancing scientific understanding, Akoya Biosciences continues to achieve significant milestones, solidifying its position as a trusted partner in the advancement of precision medicine.
DitchCarbon Score
How does Akoya Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Akoya Biosciences, Inc.'s score of 40 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Akoya Biosciences, Inc.'s reported carbon emissions
Akoya Biosciences, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no emissions figures, including Scope 1, 2, or 3 emissions, to report. In the absence of specific emissions data or reduction commitments, it is important to note that Akoya Biosciences, Inc. may still be engaging in broader industry practices aimed at sustainability and climate responsibility. However, without concrete data or targets, the company's current climate impact and commitments remain unclear.
How Carbon Intensive is Akoya Biosciences, Inc.'s Industry?
How Carbon Intensive is Akoya Biosciences, Inc.'s Location?
Akoya Biosciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Akoya Biosciences, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
